F32.9

Major depressive disorder, single episode, unspecified

Major depressive disorder (MDD), single episode, unspecified is a clinical diagnosis utilized when a patient meets the diagnostic criteria for a major depressive episode as defined in the DSM-5-TR or ICD-11, but the specific severity (mild, moderate, or severe) or the presence of psychotic features has not been determined or recorded by the clinician. The condition is characterized by a single discrete period of at least two weeks during which there is either depressed mood or the loss of interest or pleasure in nearly all activities. Pathophysiology involves complex neurobiological mechanisms, including dysregulation of the monoamine neurotransmitter systems (serotonin, norepinephrine, and dopamine), hypothalamic-pituitary-adrenal (HPA) axis hyperactivity leading to elevated cortisol levels, and reduced neuroplasticity in the hippocampus and prefrontal cortex. This diagnosis signifies a significant departure from the individual's previous level of functioning and requires clinical monitoring to assess for recurrence, which would transition the diagnosis to a recurrent major depressive disorder (F33 series).

Clinical Symptoms

  • Persistent feelings of sadness, emptiness, or hopelessness
  • Marked loss of interest or pleasure in all, or almost all, activities (anhedonia)
  • Significant unintentional weight loss or weight gain
  • Insomnia or hypersomnia nearly every day
  • Psychomotor agitation or retardation noticeable by others
  • Fatigue or loss of energy nearly every day
  • Feelings of worthlessness or excessive and inappropriate guilt
  • Diminished ability to think, concentrate, or make decisions
  • Recurrent thoughts of death or suicidal ideation
  • Vague physical aches and pains without a clear physical cause
  • Social withdrawal and isolation
  • Increased irritability or frustration even over small matters

Common Causes

  • Genetic predisposition and family history of mood disorders
  • Neurochemical imbalances in serotonin, norepinephrine, and dopamine
  • Structural and functional changes in brain regions like the amygdala and prefrontal cortex
  • Chronic or acute physiological stress leading to HPA axis dysregulation
  • Adverse childhood experiences (ACEs) and early life trauma
  • Major life transitions or stressful events such as bereavement or job loss
  • Chronic medical conditions (e.g., chronic pain, cardiovascular disease, diabetes)
  • Side effects of certain medications (e.g., corticosteroids, beta-blockers)
  • Substance use disorders involving alcohol or drugs
  • Personality traits, such as high levels of neuroticism or low self-esteem

Documentation & Coding Tips

Document specific severity levels to avoid unspecified coding

Example: Patient presents with persistent low mood and anhedonia for 3 weeks. Assessment reveals 5 out of 9 DSM-5 criteria met, including significant weight loss and insomnia, consistent with Moderate severity. Diagnosis: Major Depressive Disorder, Single Episode, Moderate (F32.1). Severity documented to support medical necessity for pharmacotherapy and to reflect accurate risk adjustment under HCC 58.

Billing Focus: Severity level (mild, moderate, severe) must be explicitly stated to support higher-level E/M coding and more granular ICD-10-CM selection.

Specify the presence or absence of psychotic features

Example: Patient reports profound hopelessness and psychomotor retardation. Denies auditory/visual hallucinations or delusional thinking. Major Depressive Disorder, Single Episode, Severe without Psychotic Features (F32.2) is diagnosed. The absence of psychosis is documented to clarify the clinical profile and support the selected treatment pathway.

Billing Focus: Inclusion of psychotic features distinguishes F32.2 from F32.3, which can significantly alter treatment complexity and resource utilization.

Capture suicidal ideation and self-harm risk explicitly

Example: Evaluation of MDD reveals passive suicidal ideation without a specific plan or intent. Patient has a history of non-suicidal self-injury (NSSI). Coded as F32.9 with additional code R45.851 for suicidal ideation. Safety plan established and documented. High MDM reflected by the risk of morbidity and management of potential self-harm.

Billing Focus: Additional R-series codes for symptoms like suicidal ideation provide a more complete clinical picture for medical necessity.

Distinguish between Single Episode and Recurrent MDD

Example: Patient currently experiencing a depressive episode. Review of longitudinal records confirms two prior treated episodes in 2021 and 2023. Current episode is a relapse. Diagnosis updated from F32.9 to F33.9 (Major Depressive Disorder, Recurrent, Unspecified) to reflect the chronic nature of the condition.

Billing Focus: Distinguishing between F32 (Single) and F33 (Recurrent) is vital for tracking the longitudinal history and justifying long-term maintenance therapy.

Record functional impairment in social and occupational domains

Example: Patient reports inability to maintain work attendance due to morning fatigue and lack of concentration. Social withdrawal from spouse and children noted. These functional impairments meet criteria for Major Depressive Disorder. Note documents the impact on daily living to support the medical necessity for intensive outpatient referral.

Billing Focus: Functional status documentation supports the level of medical decision making (MDM) by illustrating the severity of the condition's impact.

Relevant CPT Codes

Related Diagnoses

Hierarchy